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What is the sensitivity and specificity of cytology as a test for canine osteosarcoma when compared to 
histopathology as a gold standard? 
  
Clinical bottom line 
Category of research question 
Diagnosis 
The number and type of study designs reviewed 
Overall, four diagnostic validity studies (two prospective and two retrospective) were critically appraised 
Strength of evidence 
Weak to moderate 
Outcomes reported 
There is evidence of moderate strength to support that cytology is highly sensitive and specific for diagnosing 
histologically confirmed osteosarcomas as mesenchymal malignant neoplasms (cytological diagnosis of 
sarcoma). Evidence of weak strength suggests that the sensitivity and specificity of cytology for identifying 
the exact histotype (cytological diagnosis of osteosarcoma) are low and high, respectively. Finally, there is 
currently evidence of weak strength indicating that the sensitivity and specificity of cytology are comparable 
to that of preoperative histopathology after incisional biopsy for the diagnosis of canine osteosarcoma 
Conclusion 
Based on the available evidence, the diagnostic accuracy of cytology in diagnosing histologically confirmed 
osteosarcomas as sarcomas is high, whereas a confident conclusion cannot be drawn regarding the diagnostic 
accuracy of cytology for the identification of the exact histotype (cytological diagnosis of osteosarcoma). 
There is currently scant evidence suggesting that cytology has comparable diagnostic accuracy to 
preoperative histopathology (i.e. after incisional biopsy) for the diagnosis of canine osteosarcomas, however, 
more studies are warranted to confirm these results 
  
How to apply this evidence in practice 
The application of evidence into practice should take into account multiple factors, not limited to: individual 
clinical expertise, patient’s circumstances and owners’ values, country, location or clinic where you work, the 
individual case in front of you, the availability of therapies and resources. 
Knowledge Summaries are a resource to help reinforce or inform decision making. They do not override the 
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The available evidence consists of two prospective studies, one retrospective study in which the cytological 
and histopathological samples were retrieved and re-examined, and one retrospective study in which the 
initial cytological and histopathological diagnoses were utilised. Only the two retrospective studies 
investigated the diagnostic accuracy of cytology for providing a specific diagnosis of osteosarcoma and overall 
the sensitivity was low, while the specificity (reported only in one of the studies) was high; therefore, the 
evidence might be considered of weak strength and thus, clear recommendations cannot be made at this 
stage. On the other hand, cytology appears to be highly sensitive and specific for identifying malignancy (i.e. a 
generic cytological diagnosis of sarcoma); however, the current evidence should be considered of moderate 
strength, mostly due to the reported high prevalence of osteosarcoma that has probably induced a positive 
bias for the specificity. Importantly, the sensitivity and specificity of cytology was comparable to that of 
preoperative histopathology after incisional biopsy; however, the current evidence is based on a single study 
and should therefore, be considered weak overall. 
 
 
Summary of the evidence 
 
1. Loukopoulos et al. (2005) 
Population: Dogs with histologically confirmed osteosarcomas 
Sample size: 27 dogs 
Intervention details: • Preoperative cytological examination was performed, but no 
further details for the procedure are available. 
• Histopathological examination was performed, but no 
further information is available regarding the procedure. 
Study design: Diagnostic validity retrospective study 
Outcome studied: Sensitivity of cytology for the diagnosis of canine osteosarcoma 
using histopathology as a gold standard 
Main findings: 
(relevant to PICO question): 
• In 3/27 (11.1%) cases, the cytological diagnosis was not 
specific or was inconclusive. 
• In 6/27 (22.2%) cases, the cytological diagnosis was in full 
agreement with the histopathology.  
• In 13/27 (48.1%) cases, the cytological diagnosis was in 
partial agreement with the histopathology (cytological 
diagnosis of malignant neoplasia). 
• In 5/27 (18.5%) cases, the cytological diagnosis was not in 
agreement with the histopathology. 
• Therefore, the sensitivity of cytology for identifying the 
malignancy was 70.3%, while for determining the exact 
histotype was 22.2%. 
• After excluding the non-diagnostic specimens from the 
analysis, the sensitivity of cytology for diagnosing the 
malignancy and exact histotype was 79.2% and 25.0%, 
respectively. 
Limitations: • The authors retrospectively identified the cases to be 
included, but they did not retrieve the samples to re-
examine them. They relied on the initial cytological and 
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• Specificity was not reported and it could not be calculated 
based on the available data. 
• The authors did not mention if the histopathological 
diagnoses were based on post-mortem/surgical biopsies or 
preoperative incisional biopsies. 
 
 
2. Britt et al. (2007) 
Population: Dogs with aggressive appendicular bone lesions 
Sample size: 36 dogs 
Intervention details: • Fine needle aspiration (FNA) cytological examination was 
performed using a 20 gauge needle and a 12 mL syringe. The 
smears were stained with Wright-Giemsa. 
• Histopathological examination was performed after 
preoperative incisional or surgical excisional biopsy. 
Study design: Diagnostic validity prospective study 
Outcome studied: Sensitivity and specificity of FNA cytology for the diagnosis of canine 
osteosarcoma using histopathology as a gold standard 
Main findings: 
(relevant to PICO question): 
• 4/36 (11.1%) specimens were non-diagnostic. 
• 30/32 diagnostic sample cases were diagnosed as 
osteosarcomas histologically. 2/32 samples were diagnosed 
as reactive bone histologically. 
• Cytology classified 29/30 histologically confirmed 
osteosarcomas as sarcomas. One of them was diagnosed as 
reactive bone. Further classification into a specific histotype 
was not possible. 
• The sensitivity of cytology for identifying osteosarcomas as 
sarcomas was 85.3% or 96.7%, after excluding the non-
diagnostic specimens from the analysis.  
• The specificity was 100%. 
Limitations: • The prevalence of osteosarcoma was very high in this study, 
inducing inevitably a positive bias in the calculation of 
specificity. 
• The authors provided a diagnosis of sarcoma cytologically 
without attempting to specify the exact histotype. 
 
 
3. Neihaus et al. (2011) 
Population: Dogs with lytic and/or proliferative bone lesions 
Sample size: 27 dogs 
Intervention details: • FNA cytological examination was performed using a 22 
gauge needle and a 6 mL syringe. The smears were stained 
with Wright-Giemsa. 
• Core aspirate (CA) cytological examination was performed 
using a 16 gauge bone marrow biopsy needle. The smears 
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• Histopathological examination was performed after an 
incisional biopsy using Jamshidi™ needle. The sections were 
stained with haematoxylin and eosin. 
Study design: Diagnostic validity prospective study 
Outcome studied: Sensitivity and specificity of FNA and CA cytology for the diagnosis of 
osteosarcoma using histopathology as a gold standard 
Main findings: 
(relevant to PICO question): 
• 20/27 cases were diagnosed as osteosarcomas histologically. 
• FNA cytology identified 17/20 histologically confirmed 
osteosarcomas as sarcomas. 
• CA cytology identified 19/20 histologically confirmed 
osteosarcomas as sarcomas. 
• All missed cases (3/20 using FNA cytology and 1/20 using CA 
cytology) were diagnosed as reactive bone. 
• The sensitivity of FNA and CA cytology for identifying 
osteosarcomas as sarcomas was 85.0% and 95.0%, 
respectively. 
• FNA and CA cytology specificity was 100%. 
Limitations: • The prevalence of osteosarcoma was very high in this study, 
inducing inevitably a positive bias in the calculation of 
specificity. 
• The authors provided a diagnosis of sarcoma cytologically 




4. Sabattini et al. (2017) 
Population: Dogs with bone lesions 
Sample size: 68 dogs with bone lesions, 40 dogs with osteosarcomas 
Intervention details: • FNA cytological examination was performed using 21–22 
gauge needle and 2.5–5.0 mL syringe. The smears were 
stained with May-Grünwald-Giemsa. 
• Histopathological examination was performed after 
preoperative incisional biopsy using 8–11 gauge Jamshidi™ 
needle. The sections were stained with haematoxylin and 
eosin. 
• Histopathological examination was performed after surgical 
excisional biopsy or post-mortem examination. The sections 
were stained with haematoxylin and eosin. 
Study design: Diagnostic validity retrospective study 
Outcome studied: Sensitivity and specificity of FNA cytology and preoperative 
histopathology for the diagnosis of osteosarcoma using surgical or 
post-mortem histopathology as a gold standard 
Main findings: 
(relevant to PICO question): 
• In 5/40 histologically confirmed osteosarcomas, cytological 
examination was not performed. 
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• FNA cytology identified 13/35 (37.1%) osteosarcomas as 
sarcomas (10 generic sarcoma, two chondrosarcoma, one 
giant cell tumour of the bone), while 7/35 (20.0%) 
specimens were non-diagnostic. 
• The sensitivity of FNA cytology for providing a diagnosis of 
sarcoma was 80.0% (28/35). The sensitivity for identifying 
the histotype was 42.9% (15/35). 
• The calculated sensitivity of FNA cytology is 53.6% (15/28) 
for identifying the histotype and 100% for providing a 
generic diagnosis of sarcoma, when the non-diagnostic 
specimens are excluded. 
• FNA cytology diagnosed osteosarcoma incorrectly in 2/18 
(11.1%) of non-osteosarcoma lesions (one poorly 
differentiated sarcoma and one chondrosarcoma).  
• The specificity of cytology is 88.9% (16/18) for the histotype 
and 100% (18/18) for providing a generic diagnosis of 
sarcoma. 
• Preoperative histopathological examination identified 
correctly 5/11 (45.5%) osteosarcomas. In 3/11 (27.3%) 
malignancy was correctly identified by preoperative 
histopathology. 
• The sensitivity of preoperative histopathology was 45.5% 
(5/11) for the histotype and 72.8% (8/11) for malignancy. 
• The specificity of preoperative histopathology was 100%. 
Limitations: • This was a retrospective study and only a few non-neoplastic 
lesions were included as bone lesions are more likely to have 
a surgical or post-mortem histopathological examination 
when a neoplasm is suspected. Therefore, a positive bias in 
the calculation of specificity may have been induced. 
• The number of cases with both FNA cytology and 
preoperative histopathology was limited, precluding the 
comparison of the diagnostic accuracy of the two techniques 
for the same lesion. 
 
 
Appraisal, application and reflection 
 
Moderately strong evidence indicates that cytology is highly sensitive and specific for diagnosing histologically-
confirmed osteosarcomas as sarcomas. There is weak evidence suggesting that the sensitivity and specificity of 
cytology for identifying the exact histotype (i.e. osteosarcoma) are low and high, respectively. Finally, weak 
evidence suggests that the sensitivity and specificity of cytology and preoperative histopathology after 
incisional biopsy are comparable for the diagnosis of canine osteosarcoma. 
Malignant bone tumours are relatively common in dogs. Specifically, according to two studies performed in 
the USA, they account for 2–7% of all malignant neoplasias in dogs,1,2 while in one epidemiological European 
study, the incidence rate of malignant bone tumours was 5.5 cases per 10,000 dog-years at risk.3 
Osteosarcoma is by far the most common malignant bone neoplasm, accounting for up to 85% of primary 
skeletal malignant neoplasms.4 The clinicians often rely on signalment, history, clinical findings, and 
radiographical abnormalities to make a presumptive diagnosis of a malignant bone tumour. However, benign 
disorders (e.g. osteomyelitis) may exhibit similar clinical and radiographical features with malignancies, thus 
complicating the differential diagnosis. Moreover, the surgical approach, the prognosis and further post-
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malignancies. Specifically, osteosarcoma is considered a highly malignant neoplasm with a low median survival 
time and high metastatic potential, while adjuvant chemotherapy may also be required to prolong the survival 
time in these cases.5 
Incisional biopsy and histopathological examination is often recommended prior to surgery and is considered 
the gold standard for the diagnosis of primary bone lesions. However, several technique related complications, 
such as pathological fractures, haematomas, or even local seeding of neoplastic cells have been reported with 
bone biopsy.6 Moreover, the procedure requires the induction of general anaesthesia and is reportedly 
associated with enhanced patient pain.6 Fine needle aspiration (FNA) cytology is a cost-effective and less 
invasive alternative to preoperative histopathology, which is typically associated with minimal complications, 
and is characterised by a very short turnaround time.7 
Overall, four studies met the inclusion criteria for critical appraisal. The sensitivity of cytology for diagnosing 
histologically-confirmed osteosarcomas as sarcomas was high, ranging from 79.2% to 95.0%, and its specificity 
was 100% in three out of four studies.4,8–10 The sensitivity of cytology in identifying the exact histotype (i.e. 
providing a specific diagnosis of osteosarcoma rather than a generic diagnosis of sarcoma) was investigated 
only by Loukopoulos et al. (2005) and Sabattini et al. (2017), and it was found to be lower (25.0% and 42.9%, 
respectively).4,11 Conversely, the specificity was only reported by Sabattini et al. (2017) and found to be quite 
high (88.9%).4 Interestingly, Sabattini et al. (2017) compared the diagnostic accuracy of FNA cytology and 
preoperative histopathology after incisional biopsy with that of histopathology after surgical excisional biopsy 
or post-mortem examination as a gold standard. Surprisingly, the sensitivity of preoperative histopathology 
was lower than that of FNA cytology (45.5% vs 53.6% for histotype and 72.8% vs 100% for malignancy).4 This 
could be explained by some inherent limitations of the incisional biopsy as a technique to obtain bone 
samples, namely limited available tissue for evaluation due to small sample size, presence of artifacts (e.g. 
crush artifact, artifactual changes due to decalcification), or non-representative specimen (e.g. sampling of 
necrotic areas or surrounding reactive bone). This finding could be of clinical relevance as cytology is minimally 
invasive when compared to preoperative biopsy; however, more studies are warranted in order to support this 
study’s findings. Furthermore, in most of the above studies, cytology was associated with a rate of non-
diagnostic specimens, ranging from 11.1% to 20.0%,4,8,11 which highlights an inherent limitation of this 
diagnostic test. 
Even though the sensitivity of cytology for providing a specific diagnosis of osteosarcoma appears to be low, its 
high sensitivity and specificity for identifying histologically confirmed osteosarcomas as sarcomas is equally 
important for routine purposes. Specifically, the cytological examination can be easily complemented with the 
use of a special stain for alkaline phosphatase (ALP) activity, which was found to be highly sensitive (88–100%) 
and specific (89–94%) for diagnosing canine osteosarcomas.10,12 Importantly, this special staining is a simple 
and rapid test that can be performed on previously stained cytological slides.12 The main disadvantage of ALP 
staining remains the lack of specificity for malignant osteoblasts, as all osteoblasts normally express this 
enzyme.10 
All the appraised studies are diagnostic validity studies and are therefore, placed high in the evidence 
hierarchy; nonetheless, several limitations are recognised in them. Specifically, given that the calculated 
accuracy of a diagnostic test is heavily dependent on the prevalence of the target condition, the reported 
diagnostic accuracy, and especially the specificity, appears to be somewhat biased at least in the studies of 
Britt at al. (2007) and Neihaus et al. (2011),8,9 as only rare cases with a diagnosis of non-osteosarcoma were 
included. Moreover, in the aforementioned studies, the authors merely provided a cytological diagnosis of 
sarcoma without defining the exact histotype of the tumour, which thus, precludes the determination of 
diagnostic accuracy of cytology for providing a specific diagnosis of osteosarcoma. Finally, in the study of 
Sabattini et al. (2017), which was the only one that compared the diagnostic accuracy of cytology to that of 
preoperative histopathology, a low number of cases were subject to both tests, therefore, a direct comparison 
of these two tests on the same lesions was limited. 
In conclusion, there is evidence of moderate strength suggesting that cytology is highly sensitive and specific 
for providing a diagnosis of sarcoma in cases of histologically confirmed canine osteosarcomas. In terms of 
identifying the exact histotype (i.e. providing a specific diagnosis of osteosarcoma), the current evidence 
should be considered overall weak and as such, no definitive conclusions can be drawn at this stage. 
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seems to be highly specific, which is useful for excluding this type of neoplasm. Surprisingly, the currently 
available evidence suggests that the diagnostic accuracy of preoperative histopathology seems not be superior 
to that of FNA cytology for the diagnosis of osteosarcomas, although the former should be considered of weak 
strength and thus, does not allow definitive conclusions to be drawn. However, an inherent limitation of bone 
cytology is related to the rate of non-diagnostic specimens, which appears to be relatively low, but it should be 
taken into consideration and properly communicated to the owner. Prospective studies focusing on the 
diagnostic performance of cytology as compared to that of preoperative histopathology are warranted, in 
order to provide solid evidence on the use of the two techniques for the diagnosis of canine osteosarcomas 






Databases searched and dates 
covered: 
CAB Abstracts on the OVID interface 1973–2020, week 22 
PubMed accessed via the NCBI website 1920–June 2020 
Search terms: CAB Abstracts: 
1. (dog or dogs or canine or canines or canis or bitch*).mp. or exp 
dogs/ or exp bitches/ or exp canis 
2. osteosarcoma*.mp. or exp osteosarcoma/ or (bone* and 
(tumour* or tumor* or neoplasm* or cancer*)).mp. 
3. (cytology or cytopathology).mp. or exp cytology/ or (cytologic* 
and (exam* or evaluat* or diagnos*)).mp. 
4. (histopathology or histology).mp. or exp histopathology/ or 
((histologic* or histopathologic*) and (exam* or evaluat* or 
diagnos*)).mp. 
5. 1 and 2 and 3 and 4  
 
PubMed: 
(dog or dogs or canine or canines) AND (osteosarcoma) AND (cytology 
or cytopathology) AND (histology or histopathology) AND 
(veterinary[sb]) 
Dates searches performed: 11 Jun 2020 
 
 
Exclusion / Inclusion Criteria 
For the present Knowledge Summary, only original research articles were considered for inclusion, as the aim 
was to investigate measures of test performance (i.e. quantitative data) and thus, sources of qualitative 
evidence (i.e. expert opinion articles, narrative reviews) were excluded even if relevant. Conference abstracts 
were excluded as they were not likely to provide the level of detail needed for the appraisal of the evidence. 
Exclusion: • Studies investigating species other than dogs/other bone 
neoplasms 
• Case reports 
• Non-peer reviewed literature (e.g. conference abstracts, theses, 
expert opinion articles) 
• Narrative reviews 
• Studies not written in English 
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Inclusion: • Studies investigating dogs with osteosarcoma diagnosis  
• Original research articles  
• Studies investigating the diagnostic accuracy of cytology either 
alone or in comparison to histopathology 































143 113 17 4 2 3 4 
PubMed 527 449 68 6 0 0 4 
Total relevant papers when duplicates removed 4 
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